GlassScriptPhysician profile
Shaival J Kapadia
NPI 1609891985
$115,133.96
in general payments reported to CMS, 2019-2025
43 companies · $5,143 in 2025
The $5,143 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $18K · 2021: $18K · 2022: $11K · 2023: $4,831 · 2024: $3,616 · 2025: $5,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,899 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Travel and Lodging: $1,783 · Consulting Fee: $1,188 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,899.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Travel and Lodging | $1,783.01 |
| Consulting Fee | $1,187.50 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $44,103.06 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $40,230.23 | 2019-2025 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $10,743.97 | 2019-2025 | |
| Boston Scientific Corporation | $7,085.93 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Abbott Laboratories | $6,258.92 | 2019-2025 | Cardiomems, Mitraclip, Amplatzer |
| Novo Nordisk INC | $1,195.94 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $646.03 | 2019-2025 | Repatha |
| Pfizer INC. | $586.82 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $467.23 | 2021-2023 | Optimizer |
| Medtronic, INC. | $327.53 | 2021-2024 | Venaseal |
| Janssen Pharmaceuticals, INC | $320.02 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $309.42 | 2019-2020 | |
| Scpharmaceuticals INC. | $246.01 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $244.02 | 2021-2025 | Naeotom Alpha |
| Merck Sharp & Dohme LLC | $232.04 | 2021-2025 | Verquvo |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $218.25 | 2022-2025 | Onpattro |
| Edwards Lifesciences Corporation | $210.56 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $208.16 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $182.73 | 2025 | |
| Kestra Medical Technology Services, INC. | $159.48 | 2023-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $140.53 | 2019-2025 | Camzyos, Eliquis |
| Cardiac Dimensions, INC. | $132.67 | 2024 | |
| Angiodynamics, INC. | $98.85 | 2025 | Auryon Laser System 100-120 Vac |
| Sanofi-Aventis U.S. LLC | $91.38 | 2019-2022 | |
| Astellas Pharma US INC | $82.71 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $74.60 | 2020-2025 | Wainua |
| Kiniksa Pharmaceuticals International, Plc | $73.28 | 2024 | Arcalyst |
| Atricure, INC. | $69.11 | 2023 | |
| Inspire Medical Systems, INC. | $50.00 | 2023-2025 | Inspire |
| Lexicon Pharmaceuticals, INC. | $46.42 | 2023 | Inpefa |
| Gilead Sciences, INC. | $42.22 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.83 | 2025 | Lifevest |
| Bridgebio Pharma, INC. | $32.37 | 2025 | Attruby |
| Stryker Corporation | $27.60 | 2023 | N/A |
| Daiichi Sankyo INC. | $27.51 | 2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $25.83 | 2019 | |
| Heartflow, INC. | $22.21 | 2025 | |
| Livanova USA, INC. | $19.92 | 2020 | |
| Cardiva Medical, INC. | $17.98 | 2025 | Savvywire |
| Acarix USA INC. | $17.82 | 2025 | Cadscor System |
| Actelion Pharmaceuticals US, INC. | $17.58 | 2021 | |
| Lundbeck LLC | $12.19 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaival Kapadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.